FDA weighs Moderna's mRNA flu shot amid RFK Jr.'s scrutiny, after a February rejection and reversal. Approval could boost mRNA research, but funding cuts and industry fears chill innovation, impacting patients like a cancer survivor.
FDA Faces Pivotal Decision on First mRNA Flu Shot
✨ Enjoying this article? ✨
📱 Get more with the NewsNuggs iOS App →